Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

StressGen's core technology receives patent protection

Nov. 1, 1996

Three-dimensional structure of the T-cell receptor determined

Nov. 1, 1996

Takeda discloses vaccine candidates

Nov. 1, 1996

AM-94 available for licensing

Oct. 25, 1996

AM-101 available for licensing

Oct. 25, 1996

Procept seeks partners for immunosuppression, AIDS, CD2 programs

Oct. 25, 1996

Abbott to market North American Vaccine's DTaP and related vaccines

Oct. 25, 1996

Spotlight on antiinfective vaccine research in the U.S.

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

Potential Chlamydia vaccine effective in preclinical studies

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...